Daejeon, South Korea

Regen Biotech Inc.

Calculating rank
USPTO Granted Patents = 8

% Expired Patents = 62.5


Trademarks = 2

Forward Citations = 5

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal In-San Kim (4 out of 4 patents)

silverMedal Jung-Eun Kim (3 out of 3 patents)

bronzeMedal Mi Yeon Kang (2 out of 2 patents)

4.  Jeoung Yong Kim (1 out of 3 patents)

5.  Byung Chae Cho (1 out of 1 patent)

6.  Jong-Moon Jung (1 out of 1 patent)

7.  Ji-Hoon Kim (1 out of 1 patent)

8.  Eun-Ju Kim (1 out of 1 patent)

9.  Myoung-Gyu Park (1 out of 1 patent)

10.  Yong Hoon Lee (1 out of 33 patents)

11.  Won Chun Lee (1 out of 1 patent)

12.  Gun Poong Kim (1 out of 1 patent)

13.  Kun Pil Lee (1 out of 1 patent)

14.  Hang Je Choi (1 out of 1 patent)


8 patents:

Company Overview
Regen Biotech Inc. is a leading biotechnology company specializing in research and development of innovative therapies for regenerative medicine. With a focus on stem cell research and gene therapy, Regen Biotech is committed to advancing medical treatments for a wide range of diseases and conditions. Our team of scientists and researchers are dedicated to pushing the boundaries of biotechnology to improve the quality of life for patients worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

Regen Biotech Inc. USPTO Patent Assignee Logo
8 Patents

#79 in Daejeon

#1,307 in South Korea

Daejeon, KR
Daejeon, South Korea
Forward Citations = 5

14 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Regen Biotech Inc.. Retrieved from https://idiyas.com/company/regen-biotech

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…